Smoking Cessation Study for Patients With Schizophrenia or Schizoaffective Disorder

NCT00644969 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

128

Enrollment

INDUSTRY

Sponsor class

Conditions

Smoking Cessation

Interventions

DRUG: placebo
DRUG: varenicline (CP-526,555)

Sponsor

Pfizer